Related Experiment Video
Updated: Jul 5, 2026

Investigating the Alleviating Effects of Bacillus cereus Administration on Colitis through Gut Microbiota Modulation
Published on: July 27, 2022
[Changes of plasma cytokines in patients with severe hepatitis treated with a probiotic preparation]
Ming-qin Lu1, Yu Zheng, Yong-ping Chen
1Department of Infectious Diseases, First Affiliated Hospital, Wenzhou Medical College, Wenzhou 325000, China. lmq0906@163.com
Objective:
To study the changes of plasma cytokines in patients with severe hepatitis treated with a probiotic preparation.
Methods:
One hundred twelve patients with severe hepatitis treated with a basic regimen were randomly divided into a probiotic preparation treatment group and a control group. Their plasma cytokines such as tumor necrosis factor alpha, interleukin-2, interleukin-6, interleukin-10, were determined by conventional techniques.
Results:
Clinical symptoms of 84.5% of the treatment group were obviously improved. The treatment effectiveness in this group was better than that in the control group (X2=8.888). It showed that liver functions were significantly improved compared to those of the control group . After the probiotic preparation therapy, there were significant decreases in the concentrations of TNFa and IL-6. TNFa and IL-6 in the treatment group and in the control group were (109.4+/-14.7) pg/ml vs (128.7+/-18.8) pg/ml and (84.3+/-20.1) pg/ml vs (109.1+/-18.7) pg/ml respectively. However, the concentrations of IL-10 and IL-2 in the treatment group increased obviously: IL-2 was (59.8+/-12.2) pg/ml vs (47.1+/-6.7) pg/ml and IL-10 was (30.6+/-6.6) pg/ml vs (22.5+/-6.1) pg/ml.
Conclusion:
The probiotic preparation treatment effectively reduces the TNFa and IL-6 and increases the concentrations of IL-10 and IL-2 in the blood of the patients with severe hepatitis.
Related Concept Videos
Probiotics
Microbiota Modulation by Antibiotics
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents